Prostate Cancer Reports


Volume 2 Supplement 2
 February 2014
Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Supplement 2, February 2014

CONTENTS



Overall management and case reports
Treatment
Complications
Integrative medicine



OVERALL MANAGEMENT AND CASE REPORTS


Education

American Urological Association
The management of localized prostate cancer: Patient guide
AUA 2008
Abstract | Full text


Guidelines

Graham J, Baker M, Macbeth F, Titshall V; Guideline Development Group.
Diagnosis and treatment of prostate cancer: summary of NICE guidance.
BMJ. 2008 Mar 15;336(7644):610-2. doi: 10.1136/bmj.39498.525706.AD. Erratum in: BMJ. 2014;348:g394.
Abstract | Full text | Related citations



Second-line-treatment

Advanced PCa

Bahl A.
Metastatic castration-resistant prostate cancer. Part 1: the challenges of the disease and its treatment.
Eur J Oncol Nurs. 2013 Sep;17 Suppl 1:S1-6. doi: 10.1016/S1462-3889(14)70002-X.
Abstract | Related citations


Treatment comparison

Spratt DE, Zumsteg ZS, Ghadjar P, Kollmeier MA, Pei X, Cohen G, Polkinghorn W, Yamada Y, Zelefsky MJ.
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer.
BJU Int. 2013 Oct 15. doi: 10.1111/bju.12514. [Epub ahead of print]
Abstract | Related citations


Treatment complications

Fuentes-Raspall R, Inoriza JM, Rosello-Serrano A, Aun-Sanz C, Garcia-Martin P, Oliu-Isern G.
Late rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment results.
Rep Pract Oncol Radiother. 2013 Jun 21;18(5):298-303. doi: 10.1016/j.rpor.2013.05.006. eCollection 2013.
Abstract | Related citations



Charnay Sonnek F, van Muilekom E.
Metastatic castration-resistant prostate cancer. Part 2: helping patients make informed choices and managing treatment side effects.
Eur J Oncol Nurs. 2013 Sep;17 Suppl 1:S7-12. doi: 10.1016/S1462-3889(14)70003-1.
Abstract | Related citations



Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E.
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
PLoS One. 2011 Apr 6;6(4):e18625. doi: 10.1371/journal.pone.0018625.
Abstract | Full text | Related citations


Geybels MS, Neuhouser ML, Wright JL, Stott-Miller M, Stanford JL
Coffee and tea consumption in relation to prostate cancer prognosis.
Cancer Causes Control. 2013 Nov;24(11):1947-54. doi: 10.1007/s10552-013-0270-5. Epub 2013 Aug 2.
Abstract | Related citations


Lee AH, Binns CW.
Re: Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study.
J Natl Cancer Inst. 2011 Oct 5;103(19):1481; author reply 1481-2. doi: 10.1093/jnci/djr305. Epub 2011 Aug 17.
Abstract | Full text | Related citations


Polesel J, Zucchetto A, Talamini R, Dal Maso L, Serraino D, La Vecchia C, Franceschi S.
Re: coffee consumption and prostate cancer risk and progression in the health professional follow-up study.
J Natl Cancer Inst. 2012 Nov 7;104(21):1684-6; author reply 1686. doi: 10.1093/jnci/djs383. Epub 2012 Sep 6.
Abstract | Full text | Related citations


Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA.
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.
J Natl Cancer Inst. 2011 Jun 8;103(11):876-84. doi: 10.1093/jnci/djr151. Epub 2011 May 17.
Abstract | Full text | Related citations


Yaturu S, Zdunek S, Youngberg B.
Vitamin d levels in subjects with prostate cancer compared to age-matched controls.
Prostate Cancer. 2012;2012:524206. doi: 10.1155/2012/524206. Epub 2012 Dec 12.
Abstract | Full text | Related citations